Cell line · CVCL_1899
Papers31
1 to 20 of 31
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| ULK1-dependent autophagy initiation promotes MHC-I degradation and immune evasion in HPV-positive head and neck cancer. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HOXC6 overexpression stimulates cell migration and correlates with poor prognosis in head and neck squamous cell carcinoma. | Cell Mol Life Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Human papillomavirus-related oropharyngeal squamous cell carcinoma exhibits enhanced radiosensitivity despite limited activation of cytosolic DNA sensing pathways and innate immune responses. | Radiol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Epigenetic profiling reveals key super-enhancer networks driving oncogenesis in HPV-positive HNSCC. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Splicing of HPV16 E6 promotes aggressive invasion in oropharyngeal cancer via endocytosis of E-cadherin. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer. | J Transl Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells. | Neoplasia | 2025 | Its Methods give the RRID and name the line | PubMed | |
| KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival. | J Mol Biol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer. | Sci Data | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Human papillomavirus integration transforms chromatin to drive oncogenesis. | Genome Biol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis. | JCI Insight | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells. | Cancer Med | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines. | Cancers (Basel) | 2021 | Cellosaurus cites it | PubMed | |
| Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing. | PLoS One | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1899/papers